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Inner cell mass (ICM) cells of a blas-tocyst, the source of embryonic stem 
(ES) cells, are characterized by their 
unique ability to give rise to all cell 
types in adult organisms. The epig-
enomes of germ cells and developing 
zygotes undergo extensive reprogram-
ming to acquire such a pluripotent state. 
A major reprogramming event during 
early embryonic development is the era-
sure and subsequent re-establishment of 
patterns of methylation at the 5-position 
of cytosine (5mC). The recent demon-
stration that Ten-eleven translocation 
family proteins, Tet1-3 have the capac-
ity to convert 5mC to 5-hydroxymeth-
ylcytosine (5hmC) raises the possibility 
that 5hmC may act as an distinct epi-
genetic state contributing to dynamic 
changes in DNA methylation and tran-
scriptional regulation during embry-
onic development. In ES cells, Tet1 is 
highly expressed and 5hmC is present at 
relatively high levels compared to most 
differentiated cells, but the functional 
significance of Tet1 and 5hmC in these 
pluripotent cells are not clear. Recently, 
a flurry of papers that profile the distri-
bution of Tet1 and/or 5hmC across the 
genome of mouse ES cells provide new 
insights into the role of Tet proteins and 
5hmC in regulating expression of genes 
related to pluripotency and cellular dif-
ferentiation. Through integrative analy-
ses of datasets from different groups, 
we reveal the common Tet1 and 5hmC 
targets in undifferentiated mouse ES 
cells, which suggest that Tet1 may play 
a key role in orchestrating the balance 
Tet1 and 5-hydroxymethylation
A genome-wide view in mouse embryonic stem cells
Hao Wu1,2 and Yi Zhang3,4
1Cardiovascular Research Center; Massachusetts General Hospital; Boston, MA USA; 2Department of Stem Cell and Regenerative Biology; Harvard University; 
Cambridge, MA USA; 3Howard Hughes Medical Institute; 4Department of Biochemistry and Biophysics; Lineberger Comprehensive Cancer Center;  
University of North Carolina at Chapel Hill; Chapel Hill, NC USA
between pluripotent and lineage com-
mitted states.
Introduction
DNA cytosine methylation is essen-
tial for mammalian embryogenesis, and 
is dynamically regulated during early 
embryonic and germ cell development.1 
This epigenetic modification has been 
implicated in a variety of biological pro-
cesses, including retrotransposon silenc-
ing, genomic imprinting, X chromosome 
inactivation and gene regulation. While 
DNA methylation is relatively stable in 
somatic cells and is thought to be primar-
ily involved in long-term gene silencing, 
previous studies indicate that 5mC can be 
rapidly erased in zygotes independent of 
cell division, supporting the existence of 
enzymatic pathways that mediate active 
DNA demethylation.2 Despite intensive 
efforts, enzymes that are responsible for 
active DNA demethylation in mammals 
have remained elusive until recently. The 
demonstration that human TET1 and 
mouse Tet proteins have the capacity to 
convert 5mC to 5hmC has raised the pos-
sibility that Tet proteins may be part of 
the enzymatic pathway for active DNA 
demethylation.3,4
TET proteins are mammalian homo-
logs of the trypanosome base J binding 
proteins, JBP1 and JBP2, that contain 
catalytic motifs typical of Fe(II)- and 
2-oxoglutarate (2OG)-dependent dioxy-
genases.4,5 Through hydroxylation of the 
methyl group of 5mC, human and mouse 
Tet proteins can produce 5hmC.3,4 While 
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preference of Tet1 for CGI-containing 
gene promoters, probably due to the fact 
that Tet1 possesses a CXXC zinc-finger 
domain, which has a high affinity for 
nonmethylated CpG sequences.16 The 
convergence of multiple CXXC domain 
containing epigenetic regulators such as 
Cfp1,17 Kdm2a,18 and Tet1 at CpG-rich 
sequences indicates that they may synergis-
tically contribute to the establishment of a 
distinct chromatin environment at CGIs. 
In this scenario, Cfp1 confers trimethyl-
ation of lysine 4 on histone 3 (H3K4me3) 
by recruiting the H3K4me3 methyltrans-
ferase Setd1; Kdm2a binding results in the 
depletion of H3K36me2; Tet1 maintains 
a DNA hypomethylated state at CGIs. 
In support of this model, Tet1-bound 
CGIs are generally hypomethylated,13 
and depletion of Tet1 in mouse ES cells 
leads to an increase in 5mC levels at many 
CGIs.11,13,14
In addition to the presence of the tran-
scriptionally active mark H3K4me3 at 
nearly all nonmethylated CGIs15 where 
Tet1 is highly enriched in mouse ES 
cells, a subset of CGI promoters, particu-
larly those of developmentally regulated 
transcription factors, are simultaneously 
associated with repressive histone mark 
H3K27me3.19 Polycomb repression com-
plex 2 (PRC2) catalyzes H3K27me3 at 
these CGI promoters and is required for 
repression of these genes.20 Bivalent CGI 
promoters, which possess H3K4me3 as 
well as H3K27me3, account for approxi-
mately 20% of CpG-rich promoters in 
mouse ES cells.19 Interestingly, compar-
ing Tet1 bound genes to the list of biva-
lent genes indicates that a significant 
fraction of bivalent CGI promoters are 
directly bound by Tet1.11,13 In fact, a 
majority of Ezh2 and Suz12 (two core 
subunits of PRC2) co-bound sites over-
lap with Tet1 binding sites.13 Therefore, 
Tet1 can bind to both actively tran-
scribed H3K4me3-only genes and 
PRC2-repressed CpG-rich genes (Fig. 3). 
Consequently, Tet1 binding alone cannot 
predict whether a gene is active or silenced.
While there is a strong positive correla-
tion between Tet1 occupancy and CpG-
density, Tet1 also binds to a subset of 
actively transcribed CpG-poor gene pro-
moters, including pluripotency-associated 
factors such as Nanog, Tcl1 and Esrrb13 
Genome-Wide Occupancy of Tet1 
in Mouse Embryonic Stem Cells
To determine the genomic occupancy 
of Tet1 in ES cells, three groups inde-
pendently generated specific antibodies 
against Tet1 and performed chromatin 
immunoprecipitation followed by high-
throughput sequencing (ChIP-seq).11,13,14 
Although different Tet1 antibodies were 
used and sequencing depth also varied 
between studies, pairwise comparison of 
the independently derived lists of Tet1 
binding sites showed a high degree of 
overlap (Fig. 1A). For two studies with 
comparable sequencing depth of Tet1 
ChIP-seq experiments, nearly 90% of 
Tet1 bound gene promoters (n = 12,543) 
are shared (Williams et al. n = 14,077 and 
Wu et al. n = 14,440) (Figs. 1B and 3 and 
Table S1). Visual inspection of represen-
tative Tet1 target genes also confirmed 
that Tet1 binding profiles determined by 
independent studies are highly similar 
(Figs. 4 and 5).
CpG-islands (CGIs) are DNA 
sequences with densely clustered CpG 
dinucleotides. In mammalian genomes, 
roughly 70% of gene promoters overlap 
with CGIs and are generally unmethyl-
ated, whereas the bulk genomic DNA is 
predominantly methylated.15 Tet1 ChIP-
seq analyses have uncovered a strong 
5hmC is present in many tissues and cell 
types, it is relatively enriched in ES cells 
and certain types of neurons.4,6,7 Tet1 
and Tet2 are highly expressed in mouse 
ES cells and are rapidly downregulated 
upon differentiation,3,4,8 whereas Tet3 is 
expressed at very low levels in ES cells 
and upregulated during ES cell differen-
tiation. Further analysis reveals that both 
Tet1 and Tet2 are downstream targets 
of key pluripotency factors.8 In support 
of the notion that Tet proteins are criti-
cal components of a regulatory network 
in pluripotent stem cells, depletion of 
Tet proteins in mouse ES cells results in 
a partial loss of undifferentiated states 
and spontaneous differentiation towards 
trophoectoderm and endo/mesoderm 
lineages.3,8
To provide insight into the molecular 
function of Tet1 and 5hmC in pluripotent 
stem cells, we and others have recently 
undertaken genome-wide analyses of Tet1 
and 5hmC distribution as well as Tet1-
regulated genetic programs in mouse ES 
cells.9-14 Through integrative analyses of 
datasets from different groups, here we 
reveal the common Tet1 and 5hmC tar-
gets in undifferentiated mouse ES cells. 
Also, we discuss the evidence that Tet1 
may play a key role in orchestrating the 
balance between pluripotent and lineage 
committed states.
Figure 1. Comparison of tet1 genomic binding profiles derived from different groups. (A) Pairwise 
comparison between lists of tet1 binding sites identified by three independent studies. (B) venn 
diagram showing the overlap of tet1 enriched gene promoters [-2 kb to +2 kb relative to an-
notated transcription start sites (tSSs)] identified by three independent studies. Note that gene 
promoters identified by williams et al. represent a combined list of N’ and C’ antibodies.
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or chemical modification strategies have 
recently been developed to quantify locus-
specific or global levels of 5hmC in various 
tissues.7,23-25 To determine the localization 
of 5hmC in the genome of mouse ES cells, 
four groups performed 5hmC immuno-
precipitation using antibodies specifically 
Genome-Wide Distribution  
of 5hmC in Mouse Embryonic 
Stem Cells
Since the standard bisulphite sequenc-
ing technique cannot discriminate 5mC 
from 5hmC,21,22 real-time sequencing 
(Fig. 4). On these gene promoters, Tet1 
plays a crucial role in promoting a tran-
scriptionally active state by maintaining a 
nonmethylated promoter status, thereby 
allowing efficient recruitment of tran-
scription factors and basal transcriptional 
machinery.
Figure 2. Comparison of 5hmC enriched genomic loci and gene promoters identified by different groups. (A) Pairwise comparison between lists of 
5hmC enriched regions identified by four independent methods (wu et al./xu et al./Ficz et al.: 5hmC antibodies from Active Motif; williams et al.: cus-
tomized 5hmC antibodies; Pastor et al. GLiB and CMS). (B) venn diagram showing the overlap of 5hmC enriched gene promoters (-2 kb to +2 kb relative 
to annotated transcription start sites) identified by 5hmC antibody-based immunpreciptation methods (williams/wu/xu) and alternative methods 
developed by Pastor et al. (C) venn diagram showing the overlap of 5hmC enriched gene promoters (-2 kb to +2 kb relative to annotated transcription 
start sites) identified by four independent studies.
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5hmC signals obtained in wild-type 
ES cells were largely absent in Dnmt tri-
ple knockout (TKO) mouse ES cells, con-
firming that 5hmC is derived from the 
pre-existing 5mC.9,11 In addition, 5hmC 
overlaps extensively with 5mC within 
H3K36me3-marked transcribed regions, 
particularly at exons.10,12 However, many 
5hmC enriched regions are devoid of 
5mC. Notably, 5hmC enriched regions 
are frequently found at CpG-rich gene 
promoters, pluripotency transcrip-
tion factor binding sites and insulator 
CTCF binding sites,9-12 whereas 5mC 
is generally depleted from these gene 
regulatory elements,26 consistent with 
the notion that DNA methylation has 
a negative effect on most protein-DNA 
interactions.
studies (Fig. 2A). For example, 64% of 
5hmC enriched regions identified by a 
commercially available antibody (used by 
Wu et al., Ficz et al. and Xu et al.) are also 
independently confirmed by the GLIB 
method (Fig. 2A and B). 5hmC enriched 
gene promoters identified by different 
methods also largely overlap (7,260 targets 
are shared between Wu et al. n = 9,403 and 
Pastor et al. GLIB, n = 10,786) (Fig. 2B 
and C and Table S2). Interestingly, 5hmC 
modification is widely distributed across 
gene-rich regions, but is generally not pres-
ent at repetitive sequences.9,11,12,14 In addi-
tion, detailed sequencing analysis of strand 
specificity of immunoprecipitated 5hmC-
containing genomic DNA indicates that 
strand-specific 5-hydroxymethylation is 
prevalent in the non-CpG context.9
recognizing 5hmC.9,11,12,14 Pastor and col-
leagues developed two alternative meth-
ods for precipitation of 5hmC.10 The first 
approach, termed GLIB (glucosylation, 
periodate oxidation, biotinylation) uses a 
series of enzymatic and chemical steps to 
add two biotin molecules to each 5hmC; 
the second method uses antisera against 
cytosine 5-methylenesulphonate (CMS) 
which is produced when 5hmC reacts with 
sodium bisulphite. Both methods may 
possess enhanced sensitivity for detection 
of 5hmC sparsely distributed in genomic 
DNA.10 These new methods have allowed 
for the analysis of genome-wide 5hmC 
distribution.
Comparative analysis of independently 
derived lists of 5hmC enriched sites show 
a substantial overlap between the different 
Figure 3. enrichment of tet1 and 5hmC at both repressed (bivalent) and actively transcribed (H3K4me3-only) genes. Heatmap representation of 
CGis, binding profiles of tet1 (wu: GSe26833; williams: GSe24843; xu: GSe28500), 5hmC (wu: GSe27613; Pastor: GSe28682; williams: GSe24843; xu: 
GSe28500) and other epigenetic regulators/marks [ezh2 (GSe13084), H3K27me3, H3K4me3, H3K36me3 (GSe11074) and rNA Pol ii (GSe12680)] in mouse 
eS cells in two groups of genes (5-kb flanking tSSs of bivalent and H3K4me3-only genes). the heatmap is rank-ordered from genes with highest 
H3K27me3 enrichment to no enrichment within 5-kb genomic regions flanking tSSs. the following color scales were used for tet1 (wu and williams)/
ezh2/H3K27me3, tet1 (xu), 5hmC (wu), 5hmC (GLiB, CMS, williams and xu) and H3K4me3/rNA Pol ii/H3K36me3, respectively: (0, 200), (0, 50), (0, 2),  
(0, 100) and (0, 1000).
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possibly due to different turnover rate of 
5hmC at distinct genomic regions and/
or partial functional redundancy between 
Tet1 and Tet2, which may also be present 
at Tet1 bound gene promoters.
Dual Functions of Tet1 and 5hmC 
in Transcriptional Regulation
The enrichment of Tet1 and 5hmC at 
the gene promoters suggests a role for 
the Tet-mediated hydroxymethylation in 
transcriptional regulation. Depletion of 
Tet1/2 leads to a decrease in expression 
of a cohort of genes, including pluripo-
tency-related factors such as Nanog, Esrrb 
and Tcl1.3,9,13 Independent genome-wide 
mapping datasets have confirmed that 
genes functionally related to development 
(e.g., lineage-specific transcription factors) 
are highly enriched in Polycomb-repressed 
genes, whereas genes involved in house-
keeping functions are enriched in actively 
transcribed H3K4me3-only genes.13 It 
is tempting to speculate that the distinct 
patterns of 5hmC may contribute to the 
establishment and/or maintenance of dif-
ferent chromatin structures at CpG-rich 
gene promoters in mouse ES cells.
Consistent with the known enzymatic 
activity of Tet1, 5hmC is preferentially 
enriched at Tet1-bound gene promoters 
and intragenic regions.12 Tet1 depletion 
leads to a more pronounced decrease in 
5hmC levels at intragenic regions (e.g., 
exons) than at promoter regions,9,12 
Further analysis of 5hmC distribu-
tion at CGI-containing promoters indi-
cates that 5hmC is highly enriched at 
promoter regions (immediately upstream 
of TSSs and 5' end of gene bodies) of 
Polycomb-repressed genes (Figs. 3 and 
5). In contrast, 5hmC is preferentially 
enriched within intragenic regions (par-
ticularly at 3' end of gene bodies) of 
actively transcribed, H3K4me3-only 
genes. Thus, while both groups of CGI-
containing promoters are enriched with 
Tet1 and associated with low levels of 
5mC, Polycomb-repressed (bivalent) and 
actively transcribed (H3K4me3-only) 
CpG-rich promoters are marked with 
high and low levels of 5hmC, respectively. 
Gene ontology analysis indicates that 
Figure 4. enrichment of tet1 and 5hmC at representative loci of pluripotency factors. Shown are tet1 (purple), 5hmC (black) and other epigenetic 
regulator/marks (red, ezh2/H3K27me3; green, H3K4me3) at three loci encoding pluripotency-related factors. Note that only one of three alternative 
promoters of the Esrrb gene is highly expressed in mouse eS cells. ChiP-seq data are shown in reads per million with the y-axis floor set to 0.2 reads 
per million. 5hmC-chip data are show in log2 ratios (iP/input). Genomic regions with statistically significant enrichment of tet1 [p < 10-8, measured by 
-log10 (peak p value)] and 5hmC (p < 10-5 for 5hmC-seq and KS-score >2.3 for 5hmC-ChiP) are also indicated as vertical bars (tet1: purple; 5hmC: black).
www.landesbioscience.com Cell Cycle 2433
recruitment to chromatin, at least in part, 
by reducing 5mC levels at PRC2 bind-
ing sites. In addition, Tet1 may exert its 
repressive role on a subset of target genes 
by recruiting the Sin3A co-repressor com-
plex.11 Tet1 seems to repress these genes 
independent of its enzymatic activity as 
Tet1-depletion in TKO ES cells, which are 
devoid of both 5mC and 5hmC, exhib-
ited similar changes in gene expression 
on these genes.11 However, we note that 
this conclusion is in direct contrast with 
a previous study demonstrating a role of 
Tet1 enzymatic activity in transcriptional 
regulation.16 Further studies are needed to 
determine whether the capacity of Tet1 
in regulating gene expression requires its 
enzymatic activity.
Tet1 predominantly has repressive, rather 
than activating, roles on its direct target 
genes.10,11,13,14 Many Tet1-repressed target 
genes are also bound by PRC2. Although 
a direct interaction between Tet1 and 
PRC2 is not detected,11,13 Tet1 can directly 
or indirectly facilitate the recruitment 
of PRC2 to many Tet1 target genes.13 
Recent studies indicate that DNA meth-
ylation and PRC2 are generally localized 
at distinct gene promoters in ES cells or 
cancer cells,27,28 and high levels of 5mC 
may inhibit recruitment of PRC2 to chro-
matin.29,30 Moreover, at PRC2-repressed 
target genes, high level of non-proximal 
promoter DNA methylation seems to be 
associated with increased transcription.26,30 
Thus, Tet1 may positively regulate PRC2 
Tet1 and 5hmC are enriched at 5' gene 
regulatory regions of these pluripotency 
factors (Fig. 3), supporting a direct role 
for Tet1/2 and 5hmC in promoting tran-
scription of a subset of pluripotency genes. 
In agreement with this notion, depletion 
of Tet1 in mouse ES cells leads to an 
increase in 5mC levels concomitant with 
decreased expression of certain pluripo-
tency genes.9,13 Thus, in undifferentiated 
mouse ES cells, Tet1, possibly in conjunc-
tion with Tet2, are required for promoting 
transcription of a cohort of pluripotency 
factors by maintaining a hypomethylated 
state at their promoters.
Surprisingly, gene expression micro-
array or RNA-seq analysis of Tet1-
depleted mouse ES cells revealed that 
Figure 5. enrichment of tet1 and 5hmC at representative PrC2-repressed loci. Shown are tet1 (purple), 5hmC (black) and other epigenetic regulator/
marks (red, ezh2/H3K27me3; green, H3K4me3) at three loci repressed by PrC2 in mouse eS cells. ChiP-seq data are shown in reads per million with the 
y-axis floor set to 0.2 reads per million. 5hmC-chip data are show in log2 ratios (iP/input). Genomic regions with statistically significant enrichment of 
tet1 p < 10-8, measured by -log10 (peak p values) and 5hmC (p < 10-5 for 5hmC-seq and KS-score >2.3 for 5hmC-ChiP) are also indicated as vertical bars 
(tet1, purple; 5hmC, black).
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at CpG-rich gene promoters is linked to 
tumorigenesis, e.g., DNA hypermeth-
ylation mediated inactivation of tumor 
suppressor genes, and that human TET2 
gene is frequently mutated in a variety of 
haematopoietic neoplasms.31-34 We antici-
pate that future functional studies will 
further reveal the roles of Tet proteins and 
5hmC in early development and cellular 
homeostatsis.
Polycomb-repressed CpG-rich gene pro-
moters. Thus, depending on the context, 
Tet1 can associate with either active or 
repressed transcriptional states. Several 
lines of evidence suggest that this new 
epigenetic factor plays an important role 
in the establishment and/or maintenance 
of a pluripotent epigenetic state during 
early embryonic development. It is notable 
that dysregulation of DNA methylation 
Comparing independently derived lists 
of genes differentially expressed between 
control and Tet1 knockdown (KD) mouse 
ES cells (both studies used the E14Tg2A 
ES cell line) indicate a small, but statis-
tically significant overlap (Fig. 6A and 
Table S3). Since Williams and colleagues 
did not observe a downregulation of 
Nanog in Tet1-depleted cells using dis-
tinct shRNA sequences,11 they suggest 
that two Tet1 shRNA sequences used in 
our previous studies3 may represent an 
off-target effect. To further examine this 
issue, we compared multiple recently pub-
lished gene expression datasets of Tet1 
or Tet1/2-depleted mouse ES cells.9,11,13,14 
Using the list of differentially expressed 
genes identified by Wu et al. (left parts 
in Fig. 6B) or Williams et al. (right parts 
in Fig. 6B) as a reference, unbiased hier-
archical clustering analysis of log2 ratios 
of (Tet KD/Mock KD) indicates that the 
expression datasets of Williams et al. and 
other studies cluster separately (Fig. 6B). 
Since different ES cell lines and knock-
down methods were employed in each 
study (Table S4), it is unlikely that the 
observed discrepancy between Williams 
et al. and other studies are due to technical 
issues. In addition, the demonstration by 
multiple groups that Tet1 and 5hmC are 
enriched at the Nanog promoter (Fig. 4), 
and that 90% of dysregulated genes iden-
tified in our study are Tet1 direct targets,13 
as well as the fact that Tet1 knockdown 
phenotypes can be partially rescued by 
exogeneous Nanog3 all argue against 
the suggested off-target effect. Thus, it 
remains an open question as to which Tet1 
KD shRNA is more likely to have an off-
target effect. To further clarify this issue, 
knockdown followed by Tet1 rescue is 
required to definitively address the effect 
of Tet1/2 deficiency on gene expression 
networks in mouse ES cells.
Concluding Remarks
In summary, genome-wide analysis of 
Tet1 and 5hmC distribution in mouse 
ES cells sheds new light on the molecu-
lar functions of Tet proteins in mediating 
dynamic changes in 5mC and ES cell dif-
ferentiation. Tet1 deposits 5hmC marks at 
actively transcribed gene bodies as well as 
Figure 6. Comparison of differentially expressed genes in response to tet1-depletion identified 
by different groups. (A) venn diagram illustrating the overlap of independently derived lists of 
differentially expressed genes between wild-type and tet1-depleted mouse eS cells. (B) Unsuper-
vised hierarchical clustering of changes in gene expression in response to tet-depletion deter-
mined by multiple studies. Shown on the left part is the heatmap representation based on the list 
of differentially expressed genes identified by wu et al.; Shown on the right part is the heatmap 
representation based on the list of differentially expressed genes identified by williams et al.
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using following parameters (peak p value 
<10-5 and fold enrichment over IgG >10). 
5hmC enriched regions reported in Wu et 
al. and Pastor et al. (GLIB and CMS data-
sets were re-mapped to mm8 first) were 
directly obtained from Supplemental 
Tables associated with published papers. 
Visualization of 5hmC distribution at 
representative loci and in heatmap repre-
sentations was performed as described for 
Tet1 ChIP-seq datasets.
Analysis of gene expression profil-
ing datasets. To compare different gene 
expression profiling datasets, lists of dif-
ferentially expressed genes (Tet1 KD vs. 
Mock KD) reported in Wu et al. and 
Williams et al. were directly obtained from 
Supplemental Tables associated with pub-
lished papers. To calculate log2 ratios of 
expression changes between Tet KD and 
Mock KD (Affymetrix gene expression 
data), files containing normalized probe 
intensity were downloaded from the GEO 
database (Williams et al.: GSE24842; 
Xu et al.: GSE28530). For calculation 
of log2 ratios from RNA-seq datasets 
(Ficz et al.: ERP000570 in EBI Sequence 
Read Archive), raw data (FASTQ files) 
were downloaded and further processed/
mapped to annotated RefSeq transcripts 
(May, 2011; NCBI build 36/mm8) using 
TopHat (v1.2.0) with default parameters 
for single-end sequencing experiments. 
Normalized expression levels (measured 
by Fragments Per Killobase of exon model 
per Million mapped fragments, FPKM) 
for each RefSeq transcript was calculated 
using Cufflinks (v1.0.1). FPKM values 
associated with distinct transcripts from 
the same gene locus were combined to 
estimate the gene-level expression. Log2 
ratios of (Tet1/2 KD vs. Mock KD) were 
calculated with averaged FPKM values for 
each non-redundant gene locus in Mock 
and Tet1/2 KD cells. The complete link-
age hierarchical clustering (in Fig. 6B) 
was performed in Cluster 3 and visualized 
in Java TreeView.
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Materials and Methods
Analysis of Tet1 ChIP-seq datasets. To 
compare Tet1 binding sites derived from 
different studies, BED files containing 
genomic coordinates of mapped sequenc-
ing reads (NCBI build 37/mm9) were 
downloaded from the GEO database 
(Williams et al.: GSE24843; Xu et al.: 
GSE28500). Genomic coordinates were 
re-mapped to the NCBI build 36 (mm8) 
via the LiftOver tool and re-mapped 
sequencing reads were analyzed by the 
MACS program (v1.3.7.1) using identical 
parameters (peak p value <10-8 and fold 
enrichment over IgG >10) as previously 
described in reference 13. To identify Tet1 
enriched gene promoters, Tet1 peaks were 
mapped to 2-kb genomic regions flank-
ing non-redundant transcriptional start 
sites compiled from a complete set of 
Refseq genes that was downloaded from 
the UCSC Table browser (May, 2010). 
ChIP-seq datasets of Ezh2 (GSE13084), 
RNA Pol II (GSE12680), H3K4me3 and 
H3K27me3 (GSE11074) were obtained 
from previous publications and were re-
analyzed in MACS (peak p value <10-5 
and fold enrichment over input >10). For 
visualizing ChIP-seq datasets at repre-
sentative loci (Fig. 4 and 5), sequencing 
reads were binned into 400-bp windows at 
100-bp steps along the genome (mm8) as 
previously described in reference 13. For 
heatmap representations in the Figure 3, 
Tet1 enriched regions (measured by -log
10
 
peak p-value) were binned into 200-bp 
intervals at 100-bp steps within 5-kp up 
and downstream of TSSs of annotated 
RefSeq genes. The heatmap is generated 
and visualized using Cluster3 and Java 
TreeView, respectively.
Analysis of 5hmC genome-wide 
mapping datasets. To determine 5hmC 
enriched regions derived from high-
throughput sequencing of genomic DNA 
immunoprecipitated by 5hmC antibod-
ies, BED files containing genomic coor-
dinates of mapped sequencing reads 
(NCBI build 37/mm9) were downloaded 
from the GEO database (Williams et 
al.: GSE24843; Xu et al.: GSE28500). 
Genomic coordinates were re-mapped to 
NCBI build 36 (mm8) via the LiftOver 
tool and re-mapped sequencing reads were 
analyzed by the MACS program (v1.3.7.1) 
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